Pulmonary hypertension in a child with mitochondrial A3243G point mutation

Area of Science:

• Genetics and Molecular Biology
• Cardiology
• Pediatrics

Background:

• Mitochondrial diseases result from impaired mitochondrial respiratory chain function, presenting diverse clinical symptoms.
• Cardiorespiratory complications are known in mitochondrial disorders, but pulmonary hypertension is infrequently reported.
• Pulmonary hypertension involves elevated pulmonary arterial pressure, leading to right ventricular failure and carrying a poor prognosis.

Observation:

• A 3-year-4-month-old boy with a known mitochondrial A3243G point mutation presented with pulmonary hypertension.
• This case exhibits an unusual association between a specific mitochondrial mutation and severe pulmonary complications.

Findings:

• The patient's presentation suggests a link between the A3243G mitochondrial mutation and the development of pulmonary hypertension.
• This case expands the spectrum of known clinical manifestations associated with mitochondrial respiratory chain dysfunction.

Implications:

• Pulmonary hypertension should be considered a potential, albeit rare, clinical manifestation in patients with mitochondrial diseases.
• Further research is warranted to understand the mechanisms linking mitochondrial dysfunction to pulmonary hypertension and to improve patient outcomes.